Axon Therapies

About:

Axon Therapies develops a healthcare device with a neuromodulation approach to treat heart failure.

Website: https://www.axontherapies.com

Top Investors: Deerfield, Action Potential Venture Capital

Description:

Axon Therapies developed the SAVM procedure. Their novel approach to modulating the body’s sympathetic nervous system to restore balance in the circulatory system.

Total Funding Amount:

$3.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

2014-01-01

Founders:

Howard Levin, Mark Gelfand, Zoar Engelman

Number of Employees:

11-50

Last Funding Date:

2019-07-03

IPO Status:

Private

Industries: